Safety experts to review AstraZeneca vaccine jab
The European Medicines Agency (EMA) - the European Union's medicines regulator - is also meeting on Tuesday. It has previously said that people can continue receiving the vaccine
Vaccine safety experts from the World Health Organization (WHO) are meeting on Tuesday to review the Oxford-AstraZeneca jab, after a number of countries paused their rollouts.
Countries including France and Germany said they were acting as a precaution amid reports of blood clots in some recipients in Europe, reports the BBC.
The WHO says there is no evidence of a link between clots and vaccines.
Keep updated, follow The Business Standard's Google news channel
It has urged countries not to pause their vaccinations.
The European Medicines Agency (EMA) - the European Union's medicines regulator - is also meeting on Tuesday. It has previously said that people can continue receiving the vaccine.
AstraZeneca says a review of 17 million people who received doses in Europe found there were 37 cases of people who had developed blood clots.
Experts say the number of blood clots reported in vaccinated people is no higher than that seen in the general population.
